Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of sublingual immunotherapy with depigmented-polymerized pollen extracts for allergic rhi…
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: Validation of an Environmental Exposure Chamber for Inhalation Studies With House Dust Mite Allergen in Patients With Allergic Rhinitis [NA]
This clinical trial update reports on the validation of an environmental exposure chamber for inhalation studies using house dust mite aller…
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: 3-D Visualization of the Anti-Obstructive Effect of Levocetirizine [Phase 3]
Phase 3 trial update on levocetirizine for allergic rhinitis, featuring 3-D visualization of anti-obstructive effects; study status is compl…
-
CLINICAL_TRIALS trial_result · 2011-06-20Clinical Trial Update: Glycyphagus Domesticus Allergen Extract. Determination of the in Vivo Biological Activity in Histamine Equivalent Units (HEP). [Phase 2]
Phase 2 trial evaluating the in vivo biological activity of Glycyphagus domesticus allergen extract using histamine equivalent units (HEP) a…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma [Phase 2]
Phase 2 dose-finding study of Depigoid Birch in patients with allergic rhinitis, rhinoconjunctivitis, with or without asthma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-20Clinical Trial Update: Safety and Tolerability of ToleroMune Grass in Grass Allergic Subjects With Rhinoconjunctivitis [Phase 2]
Phase 2 trial update reporting safety and tolerability of ToleroMune Grass in individuals with grass pollen–induced allergic rhinitis (rhino…
-
CLINICAL_TRIALS trial_result · 2011-05-05Clinical Trial Update: Study to Investigate Effects of CAL-263 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber [Phase 1]
Phase 1 trial evaluating CAL-263 for allergic rhinitis completed; study assessed effects of CAL-263 in subjects exposed to allergen in an en…
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: Efficacy of SLITone in House Dust Mite Allergic Patients [Phase 2, Phase 3]
Phase 2/3 trial updates show efficacy results for SLITone in house dust mite–related allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2011-02-15Clinical Trial Update: Evaluation Effects of Nasal Nitric Oxide Measurements Are Associated With Atopy Status in Chronic Nasal Inflammation
A completed clinical trial evaluated how nasal nitric oxide measurements relate to atopy status in individuals with chronic nasal inflammati…
-
CLINICAL_TRIALS trial_result · 2011-02-14Clinical Trial Update: Interaction Effect of Asthma and Aeroallergen Category on the Psychological Status in Allergic Rhinitis Patients
A completed clinical trial examined how asthma status and aeroallergen category influence psychological status in patients with allergic rhi…
-
CLINICAL_TRIALS trial_result · 2011-02-08Clinical Trial Update: Distinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children [NA]
The clinical trial evaluating cluster-specific immunotherapy in children with allergic rhinitis has completed. It reports distinct responses…
-
CLINICAL_TRIALS trial_result · 2011-02-04Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis [Phase 3]
Phase 3 randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of fluticasone furoate nasal spray for two wee…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Assess the Efficacy and Safety of Rhinocort Aqua [Phase 2]
This entry reports the completion of a Phase 2 trial evaluating the efficacy and safety of Rhinocort Aqua (budesonide nasal spray) for aller…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine [Phase 4]
Phase 4 trial evaluating fexofenadine, desloratadine, and placebo for suppression of wheal and flare in allergic rhinitis has been completed…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen [Phase 4]
Phase 4 trial evaluating whether fexofenadine HCl 180 mg plus montelukast sodium 10 mg reduces wheal and flare responses to seasonal allerge…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine [Phase 4]
Phase 4 trial evaluating the pharmacokinetics and safety of fexofenadine in healthy adults who are slow metabolizers of desloratadine.
-
CLINICAL_TRIALS trial_result · 2011-01-05Clinical Trial Update: A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis [Phase 4]
This Phase IV open-label trial evaluated the safety and tolerability of once-daily AVAMYS nasal spray (fluticasone furoate) 110 mcg in Vietn…
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: Immunotherapy With Depigmented and Polymerized Allergen Extract of Olea Europaea (GPIT) [Phase 3]
Phase 3 trial of depigmented and polymerized Olea europaea allergen extract (GPIT) for allergic rhinoconjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense [Phase 2]
Phase 2 trial evaluating depigmented and polymerized Phleum pratense allergen extract for allergic rhinitis, allergic conjunctivitis, and as…
-
CLINICAL_TRIALS trial_result · 2010-11-24Clinical Trial Update: Efficacy of Sublingual Immunotherapy in Polysensitized Allergic Rhinitis Patients [NA]
A completed clinical trial evaluating the efficacy of sublingual immunotherapy in patients with polysensitized allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684) [Phase 3]
Phase 3 study evaluating desloratadine for persistent allergic rhinitis (Study P04684) has completed with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-11-15Clinical Trial Update: Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy [Phase 2]
Phase 2 dose-finding trial of CYT003-QbG10 for house dust mite–induced rhinoconjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With Rhinoconjunctivitis [Phase 2]
Phase 2 trial evaluating the safety of ToleroMune Ragweed in ragweed-allergic individuals with rhinoconjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Safety of ToleroMune House Dust Mite (HDM) to Treat House Dust Mite Allergy in HDM Allergic Subjects With Rhinoconjunctivitis [Phase 2]
This clinical trial update notes the completion of a Phase 2 study evaluating the safety of ToleroMune for house dust mite allergy in subjec…
-
CLINICAL_TRIALS trial_result · 2010-09-27Clinical Trial Update: Safety and Tolerability of Single and Multiple Doses of VAK694 in Healthy and Atopic Subjects [Phase 1]
Phase 1 study evaluating the safety and tolerability of single and multiple doses of VAK694 in healthy and atopic subjects, including indivi…